Showing results (11-20 of 289) with videos related to
Sort By:
Pageof 29
Pharmaceutical Statistics|October 2, 2020
Recurrent time-to-event models with ordinal outcomesVal Gebski, Karen Byth, Rebecca Asher, et al.Pharmaceutical Statistics|March 18, 2021
Using recurrent time-to-event models with multinomial outcomes to generate toxicity profilesVal Gebski, Ian Marschner, Rebecca Asher, et al.International Journal of Epidemiology|February 15, 2018
Data maturity and follow-up in time-to-event analysesVal Gebski, Valérie Garès, Emma Gibbs, et al.Head & Neck|January 1, 2005
Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neckMichael J Veness, Gary J Morgan, Val GebskiInternational Journal of Radiation Oncology, Biology, Physics|November 27, 2009
The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patientsMichael Veness, Matthew Foote, Val Gebski, et al.Journal of Speech, Language, and Hearing Research : JSLHR|August 16, 2006
Guidelines for statistical analysis of percentage of syllables stuttered dataMark Jones, Mark Onslow, Ann Packman, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2018
Disease-Free and Survival Outcomes for Total Laparoscopic Hysterectomy Compared With Total Abdominal Hysterectomy in Early-Stage Endometrial Carcinoma: A Meta-analysisRebecca Asher, Andreas Obermair, Monika Janda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2024
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical CancerPedro T Ramirez, Kristy P Robledo, Michael Frumovitz, et al.BMC Medical Research Methodology|February 28, 2022
Distributional regression in clinical trials: treatment effects on parameters other than the meanGillian Z Heller, Kristy P Robledo, Ian C MarschnerInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2026
Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intra-uterine device for endometrial hyperplasia and adenocarcinoma: results from the feMMe phase 2 randomized clinical trialEva Baxter, Kristy P Robledo, Monika Janda, et al.Pageof 29